Abstract Depression is one of the most common psychiatric disorders causing considerable economic burden. However, current treatment as usual, pharmacotherapy and psychotherapy, provides unsatisfactory outcome for majority patients in cases fails to prevent resistance chronicity. tDCS, has emerged a new neuromodulation shown efficacy depressed patients. To provide important insight payers, cost...
